assertio reflects an aspirational mindset that is forward thinking, energetic, and entrepreneurial in spirit. ticker symbol: asrt
Company profile
Ticker
ASRT
Exchange
Website
CEO
Todd N. Smith
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Assertio Therapeutics, Inc, DEPOMED INC, DEPOMED INC
SEC CIK
Corporate docs
Subsidiaries
Assertio Therapeutics, Inc. • Depo DR Sub, LLC • Depo NF Sub, LLC • Assertio Management, LLC • Assertio Distribution, LLC • Alligator IP, LLC • Zyla Life Sciences, LLC • Zyla Life Sciences US, LLC • Otter Pharmaceuticals, LLC • Spectrum Pharmaceuticals, Inc. ...
IRS number
850598378
ASRT stock data
Latest filings (excl ownership)
PRE 14A
Preliminary proxy
9 Apr 24
8-K
Departure of Directors or Certain Officers
2 Apr 24
8-K
Other Events
27 Mar 24
8-K/A
Results of Operations and Financial Condition
12 Mar 24
S-3
Shelf registration
11 Mar 24
10-K
2023 FY
Annual report
11 Mar 24
8-K
Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
11 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Feb 24
8-K
Departure of Directors or Certain Officers
26 Jan 24
8-K
Departure of Directors or Certain Officers
5 Jan 24
Transcripts
ASRT
Earnings call transcript
2023 Q4
11 Mar 24
ASRT
Earnings call transcript
2023 Q3
8 Nov 23
ASRT
Earnings call transcript
2023 Q2
3 Aug 23
ASRT
Earnings call transcript
2023 Q1
10 May 23
ASRT
Earnings call transcript
2022 Q4
8 Mar 23
ASRT
Earnings call transcript
2022 Q3
9 Nov 22
ASRT
Earnings call transcript
2022 Q2
8 Aug 22
ASRT
Earnings call transcript
2022 Q1
10 May 22
ASRT
Earnings call transcript
2021 Q4
9 Mar 22
ASRT
Earnings call transcript
2021 Q3
4 Nov 21
Latest ownership filings
3
Sigurd Kirk
9 Apr 24
4
James L Tyree
15 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
4
Sam Schlessinger
23 Feb 24
4
Paul Schwichtenberg
23 Feb 24
4
Ajay Patel
23 Feb 24
SC 13G
Nantahala Capital Management, LLC
14 Feb 24
SC 13G/A
CONTINENTAL GENERAL INSURANCE CO
14 Feb 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Sam Schlessinger
13 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 76.89 mm | 76.89 mm | 76.89 mm | 76.89 mm | 76.89 mm | 76.89 mm |
Cash burn (monthly) | (no burn) | (no burn) | 76.30 mm | 17.62 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 507.44 mm | 117.19 mm | n/a | n/a |
Cash remaining | n/a | n/a | -430.55 mm | -40.30 mm | n/a | n/a |
Runway (months of cash) | n/a | n/a | -5.6 | -2.3 | n/a | n/a |
Institutional ownership, Q2 2023
38.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 149 |
Opened positions | 57 |
Closed positions | 26 |
Increased positions | 48 |
Reduced positions | 31 |
13F shares | Current |
---|---|
Total value | 161.34 bn |
Total shares | 36.60 mm |
Total puts | 300.50 k |
Total calls | 2.41 mm |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 3.88 mm | $21.04 bn |
Continental General Insurance | 3.74 mm | $20.07 mm |
Vanguard | 2.76 mm | $14.98 bn |
D. E. Shaw & Co | 2.32 mm | $830.00 k |
Renaissance Technologies | 1.56 mm | $8.48 bn |
Intrinsic Edge Capital Management | 1.20 mm | $6.50 bn |
Geode Capital Management | 1.10 mm | $5.98 bn |
First Eagle Investment Management | 1.04 mm | $5.62 bn |
STT State Street | 951.54 k | $5.16 bn |
Divisadero Street Capital Management | 850.00 k | $4.61 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Mar 24 | Tyree James L | Common Stock | Sell | Dispose S | No | No | 1.1182 | 10,251 | 11.46 k | 188,251 |
11 Feb 24 | Sam Schlessinger | Common Stock | Payment of exercise | Dispose F | No | No | 0.8 | 6,552 | 5.24 k | 92,233 |
11 Feb 24 | Sam Schlessinger | Common Stock | Option exercise | Acquire M | No | No | 0 | 18,939 | 0.00 | 98,785 |
11 Feb 24 | Sam Schlessinger | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 18,939 | 0.00 | 0 |
11 Feb 24 | Paul Schwichtenberg | Common Stock | Payment of exercise | Dispose F | No | No | 0.8 | 16,382 | 13.11 k | 95,279 |
11 Feb 24 | Paul Schwichtenberg | Common Stock | Option exercise | Acquire M | No | No | 0 | 47,348 | 0.00 | 111,661 |
11 Feb 24 | Paul Schwichtenberg | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 47,348 | 0.00 | 0 |
11 Feb 24 | Ajay Patel | Common Stock | Payment of exercise | Dispose F | No | No | 0.8 | 16,382 | 13.11 k | 124,609 |
11 Feb 24 | Ajay Patel | Common Stock | Option exercise | Acquire M | No | No | 0 | 47,348 | 0.00 | 140,991 |
11 Feb 24 | Ajay Patel | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 47,348 | 0.00 | 0 |
Press releases
Assertio to Present at LD Micro Invitational Conference in New York City
1 Apr 24
ASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
27 Mar 24
Thinking about buying stock in Marathon Digital, Assertio, Ocean Biomedical, Terns Pharmaceuticals, or NextCure?
12 Mar 24
Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
11 Mar 24
March 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ASRT
5 Mar 24